Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Skeletal myoblasts are mononucleated progenitor (precursor) cells that arise from the paraxial mesoderm during development and remain resident in adult skeletal muscle as satellite cells. Upon activation (for example, in response to muscle injury), they proliferate and then differentiate by fusing to form multinucleated myotubes, which mature into skeletal muscle fibers. These cells express molecular markers such as Pax7, MyoD, and desmin, and play an essential role in skeletal muscle formation, regeneration, and repair throughout life. In regenerative medicine, skeletal myoblasts have been explored as a potential cell therapy for myocardial repair and muscular dystrophies; however, they are not a single molecular target but a cell population, and thus are not directly druggable in the sense of conventional receptors or enzymes[1][3][4][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Skeletal myoblast.